Purchase Order 75N94023P00093
Award Date
1/1/23
Potential Completion Date
11/2/24
Potential Value
$139K
Federal Agency
National Institute of Child Health and Human Development
Awardee
Pine Pharmaceuticals LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Tonawanda, NY 14150, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $15,000 firm fixed-price delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a for-profit limited liability company. The contract is for the provision of non-severable task order 1 for metabolic isotopes to support research studies conducted by various HHS agencies. Pine Pharmaceuticals is an FDA-registered 503B...
This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The $12,580.80 contract is for the acquisition of intravenous stable isotopes, which are specialized pharmaceutical compounds used in metabolic and clinical research studies. Pine Pharmaceuticals is an...
The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases has awarded a $15,400 firm fixed price purchase order to Pine Pharmaceuticals LLC. The contract is for the delivery of 6,6 D2Glucose intravenous stable isotopes to support metabolic research studies being conducted by NIDDK in Tonawanda, New York. Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility specializing in high-quality pharmaceutical compounds and repackaged products, with...
This is a federal delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company. The $158,877.60 firm fixed price contract is for the provision of metabolic isotopes, a non-severable service, with a performance period ending on April 13, 2026. Pine Pharmaceuticals is an FDA-registered 503B outsourcing...
This is a $121,989 firm fixed-price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract is to provide specialized pharmaceutical products and services, including the manufacture of stable isotopes, placebo capsules, and other compounds used in medical...
This is a $27,384.76 firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract is for the provision of 3 batches/shipments of 60 units each of the intravenous stable isotope D5 glycerol, which is required for metabolic research studies conducted...
The National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $237,922.80 firm fixed price purchase order to Pine Pharmaceuticals LLC. The purpose of this acquisition is to procure an intravenous stable isotope to support metabolic research studies being conducted by the funding agency. The solicitation sought a stable isotope that meets NIH specifications for use in clinical human research, referencing a history of safe use in such studies. No...
This federal contract award was made by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The $173,631.31 firm fixed-price purchase order was awarded on September 22, 2016, with a completion date of September 21, 2017. The contract is for the provision of a drug necessary for use in the NCATS II...
This is a federal contract award to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract, valued at $37,117.80, is a delivery order from the U.S. Department of Veterans Affairs Veterans Health Administration (VA VHA) for 503B compounding pharmaceutical services. The contract has a period of performance ending on September 30, 2024. Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility that specializes in pharmaceutical...
<p>The National Institute of Child Health and Human Development (NICHD) awarded a firm-fixed-price purchase order contract to US Specialty Formulations LLC, a small disadvantaged business, for the delivery of sterile injectable supplies. The $238,122.00 contract has a period of performance through May 17, 2023 and is set aside for small businesses. NICHD is a civilian agency that focuses on research related to child health and development.</p>